Nordic Aid - Company finances
|
EUR
|
2024
From: 2024-04-09
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|
|
Financial data
|
||
| Sales revenue | 3,691,696 | 11,173,836 |
| Profit before tax | 317,600 | 1,174,179 |
| Net profit | 269,717 | 986,933 |
| Equity | 272,217 | 965,033 |
| Liabilities | 335,558 | 510,094 |
| Non-current assets | 18,806 | 21,770 |
| Current assets | 588,279 | 1,452,241 |
| Total assets | 607,085 | 1,474,011 |
|
Taxes paid
|
||
| STI taxes | 8,193 | 96,700 |
| Social insurance contributions | - | 19,813 |
|
Financial indicators
|
||
| Revenue change y/y | - | +202.7% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 44.4% | 67.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 99.1% | 102.3% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 7.3% | 8.8% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 8.6% | 10.5% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 1.2 | 0.5 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 1,954,416 | 3,118,309 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Nordic Aid - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2024-12-22 | 2024-12-31 | 0.12 |
| 2024-12-17 | 2024-12-20 | 0.12 |
| 2024-11-18 | 2024-12-08 | 0.12 |
| 2024-10-24 | 2024-11-07 | 0.12 |
Nordic Aid - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Nordic Aid, UAB (code 306720794) is a Private Limited Liability Company engaged in the wholesale of pharmaceutical and medical goods. In the latest financial year, 2025, the company generated revenue of €11.17M and net profit of €986.9K, representing a profit margin of 8.8%. Revenue increased strongly year on year by 202.7% from €3.69M in 2024, while net profit also rose from €269.7K to €986.9K. The two-year trajectory shows rapid scaling in both turnover and earnings, with profitability improving alongside growth. At the end of 2025, total assets stood at €1.47M, supported by equity of €965.0K and liabilities of €510.1K. The equity ratio was 65.5% and debt-to-equity was 0.53, indicating a relatively solid capital structure. Efficiency indicators were also strong, with asset turnover at 7.58x, ROE at 102.3% and ROA at 67.0%. Based on staff data, revenue per employee reached €3.72M and profit per employee €329.0K.